In ESCC and Nasopharyngeal carcinoma (NPC), ADAMTS9 functions as a tumor suppressor, inhibiting tumor growth through suppressing angiogenesis [77]. Here, ADAMTS9 is linked to esophageal squamous cell carcinoma.